Skip to main content
Fig. 3 | Critical Care

Fig. 3

From: Thromboxane–prostaglandin receptor antagonist, terutroban, prevents neurovascular events after subarachnoid haemorrhage: a nanoSPECT study in rats

Fig. 3

Early (day 2) and delayed (day 5) functional outcomes. a Changes in body weights (% of day 0). Bars indicate the mean and SD measured in rats of sham group (n = 13), CSF group (n = 15), SAH group (n = 15) or SAH+TBN group (n = 14). b Garcia scores measured on days 2 (D2, early effects) and 5 (D5, delayed effects). Bars indicate the mean and SD measured in rats of sham group (n = 12), CSF group (n = 15), SAH group (n = 15) or SAH+TBN group (n = 12); *P < 0.05 compared to sham, **P < 0.05 compared to CSF, §P < 0.05 compared to SAH. CSF denotes cerebrospinal fluid; SAH, subarachnoid haemorrhage; TBN, terutroban

Back to article page

Critical Care

ISSN: 1364-8535